Back to News
Market Impact: 0.3

The 2 Best Nuclear Energy Stocks to Buy Right Now

BWXTNFLXNVDANDAQ
Artificial IntelligenceTechnology & InnovationInfrastructure & DefenseCorporate EarningsCompany FundamentalsAnalyst InsightsEnergy Markets & Prices
The 2 Best Nuclear Energy Stocks to Buy Right Now

BWX Technologies and Rolls-Royce are highlighted as lower-risk ways to gain exposure to the SMR/nuclear power theme driven by AI data center electricity demand. BWXT’s BANR is a 75 MW reactor aimed at data centers, while Rolls-Royce’s SMR is a larger 470 MW design selected for the U.K. SMR competition and under agreement with ČEZ. The article also notes solid operating fundamentals: BWXT 2025 revenue rose 18% to $3.19 billion with 10.31% net margin, while Rolls-Royce revenue rose 12.15% to $21.21 billion with EPS up from $0.30 to $0.69 and a 27.52% net margin.

Analysis

The real market implication is not “nuclear is back,” but that AI power demand is starting to value optionality in regulated, capital-intensive infrastructure rather than pure-play tech. BWXT and RYCEY are interesting because their core businesses subsidize long-dated SMR development, which materially lowers financing risk versus venture-stage reactor developers; that funding advantage is likely to become a strategic moat if customers begin demanding bankable vendors rather than concept-stage promises. The second-order winner set extends beyond the names in the article to specialty nuclear supply chain, component qualification, and engineering services, where incumbent certification know-how should matter more than headline reactor design. The market is still underpricing the gap between prototype enthusiasm and commercial deployment. Even if demand is real, the path from design selection to grid-connected revenue is likely measured in years, not quarters, and the biggest failure mode is not technology alone but permitting, fuel supply, and offtake contracting. That creates a classic “good story, slow cash flow” setup: equities can rerate on announcements, but fundamentals will not inflect until project finance and regulatory milestones are de-risked. Contrarianly, the current enthusiasm may be better for the ecosystem than for the reactor OEMs themselves. If AI infrastructure buyers want near-term electrons, they may prefer gas, batteries, grid upgrades, or long-term PPAs over waiting for SMRs, which limits the immediate monetization of the thesis. The more investable near-term angle is on companies that sell the picks-and-shovels of licensing, fuel fabrication, defense-adjacent nuclear engineering, and high-spec manufacturing rather than the narrow SMR end-market. A further risk is that successful SMR commercialization compresses the scarcity premium in the rest of the power stack: utility-scale gas turbines, transmission bottlenecks, and grid operators could see less urgency if nuclear optionality becomes credible. But if the first few deployments slip or costs inflate, sentiment could unwind quickly because the valuation support is mostly narrative-driven today. That makes catalyst monitoring critical: regulator approvals, customer LOIs converting to firm orders, and construction timelines will matter more than general bullish commentary.